Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-251788
Filing Date
2024-11-06
Accepted
2024-11-06 10:26:57
Documents
2
Group Members
FHMLS IX, L.L.C.FHMLS IX, L.P.JAMES TOPPERPATRICK HERON

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d898648dsc13ga.htm SC 13G/A 108230
2 EX-99.A d898648dex99a.htm EX-99.A 9621
  Complete submission text file 0001193125-24-251788.txt   119562
Mailing Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101
Business Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101 206-254-7200
Frazier Life Sciences IX, L.P. (Filed by) CIK: 0001720320 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Subject) CIK: 0001819790 (see all company filings)

EIN.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91774 | Film No.: 241429569
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)